HEALTH
SOLUTION FOR ALL NEED
Expanding capacity and supporting the global ecosystem
Learn how Pekin Pharma expanding capacity and supporting the global ecosystem
With the changing market demand and the continuous progress of technology, the company began to enter the field of high-tech products such as biosimilar drugs and medical devices in 2019. Through close cooperation with well-known enterprises at home and abroad, the company has successfully introduced a series of advanced biomedical development and production technology, to provide customers with more comprehensive and professional services.
In terms of upstream partners, Pekin Pharma works with Jiangsu Zhonghui Import and Export Co., LTD., Intellective Bio (Suzhou) Co., LTD., and (ZHEJIANG)BioRay Pharmaceutical Co.,Ltd. And outstanding enterprises such as HALOLIFE (XIAMEN) TECHNOLOGY CO.,LTD have established long-term and stable cooperative relations. These partners have strong research and development and production capabilities in their respective fields, and provide Peikin with rich product resources and technical support.
In terms of downstream customers, the company's customers are mainly distributed in Algeria, Morocco, Iraq, UAE, Turkey, Jordan and Egypt and other Middle East and North African countries. With excellent product quality and professional service, the company has won wide recognition and trust from customers.
Starting in 2024, , the company will focus on expanding its agent sales and clinical business of biosimilar Adalimumab and domestic PD-1 drugs in the Middle East region. In addition, the company plans to complete a turnkey project in the Middle East of $25 million in 2024-2025.
-
IMPACT
In expanding our own and our partners’ capacity, we are:
▪ cultivating a vibrant ecosystem of biotechnology innovation focused on addressing
Global health challenges
▪ Create more jobs in the Middle East, North Africa, Europe and partner countries
▪ Support our mission as a hub for biofamination in the Middle East and EuropeIn addition to improving accessibility, this expansion of capacity increases the speed and efficiency of biologic production. Building infrastructure that is closer to the end user reduces the time and costs associated with transportation and logistics.
Simultaneously, we’re channeling learnings from our diverse partnerships around the world. This is helping ensure that best practices and key insights are shared with the stakeholders which helps set the agenda at the global and regional levels.
-
Contact
PEKIN PHARMA GROUP LTD.
Tel: +852 62336759
E-mail: info@pekin-pg.com
Address:H020 3/F PHASE 2 KWAI SHING IND BLD. 42-46 TAI LIN PAI RD. KWAI CHUNG NT, HONG KONG, CHINA.
Message